Effectiveness of Simeprevir plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection

BACKGROUND & AIMS: The interferon-free regimen of simeprevir plus sofosbuvir was recommended by professional guidelines for certain patients with hepatitis C virus (HCV) genotype 1 infection based on the findings of a phase 2 trial. We aimed to evaluate the safety and efficacy of this regimen in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gastroenterology
Autori principali: Sulkowski, MS, Vargas, HE, Di Bisceglie, AM, Kuo, PA, Reddy, KR, Lim, JK, Morelli, G, Darling, JM, Feld, JJ, Brown, RS, Frazier, LM, Stewart, TG, Fried, MW, Nelson, DR, Jacobson, IM
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727992/
https://ncbi.nlm.nih.gov/pubmed/26497081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2015.10.013
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi